Fulcrum Therapeutics (FULC) Treasury Shares (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Treasury Shares data on file, last reported at $90.1 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 102222.6% year-over-year to $90.1 million in Q1 2026; TTM through Mar 2026 was $90.1 million, a 102222.6% increase from a year earlier, with the FY2025 full-year figure at $69.5 million, up 161225.22% from the prior year.
• Treasury Shares for Q1 2026 stood at $90.1 million, up from $69.5 million in the prior quarter.
• Over the last five years, Treasury Shares for FULC reached as high as $90.1 million in Q1 2026 and fell as low as $43072.0 in Q4 2024.
• Historically, Treasury Shares has averaged $17.7 million across 5 years, with a median of $95174.0 in 2022.
• Across the five-year window, Treasury Shares slumped 42.58% in 2024 and jumped 161225.22% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $76718.0 in 2022, then decreased by 2.22% to $75017.0 in 2023, then slumped by 42.58% to $43072.0 in 2024, then soared by 161225.22% to $69.5 million in 2025, then rose by 29.66% to $90.1 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $90.1 million in Q1 2026, $69.5 million in Q4 2025, and $69.5 million in Q3 2025.